Mount Sinai Morningside · 1 week ago
Postdoctoral Fellow-MSH-12907-055
New York, NY
Full-time
Onsite
Entry Level
$72K/yr - $80K/yr
1+ years expMount Sinai Morningside is a leading academic medical system committed to excellence in healthcare. The Postdoctoral Fellow will focus on the characterization of a novel TGFB-related axis driving cholangiocarcinoma growth, involving the generation of gene delivery-based mouse models and drug screenings.
Hospital & Health Care
Responsibilities
The research study focuses on the characterization of a novel TGFB-related axis driving cholangiocarcinoma growth. The main aspects of the research include: i) the generation of gene delivery-based mouse models; ii) molecular and immunophenotypic analyses of murine tumors; iii) generation and maintenance of ex-vivo cultures; and iv) in vitro and in vivo drug screenings
The main aspects of the research include: i) the generation of gene delivery-based mouse models; ii) molecular and immunophenotypic analyses of murine tumors; iii) generation and maintenance of organoid cultures; and iv) in vitro and in vivo drug screenings. The responsibilities include generation of the mouse models above mentioned, characterization of resulting tumors and establishment of organoids for drug screening. In addition, data analysis and results interpretation are expected
Qualification
Required
PhD in cancer biology or related field
experience with animal work (at least 1 year)
Company
Mount Sinai Morningside
At Mount Sinai Morningside, we offer exceptional clinical care and research within the comfort of a neighborhood hospital known for compassion and sensitivity.
1001-5000 employees
H1B Sponsorship
Mount Sinai Morningside has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageLeadership Team
Faye Reiff-Pasarew
Deputy CMO, Associate Chief of Hospital Medicine, Assistant Professor of Internal Medicine
Lucy Xenophon, MD, MPH
Chief Transformation Officer
Company data provided by crunchbase